Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Altmueller, Janine Dr.med. (29) Chekulaeva, Marina Dr. (1) Daniel, Peter Prof. Dr. (1) Fischer, Cornelius Dr. (1) Harabula, Izabela-Cezara (1) Hirsekorn, Antje (1) Kammertöns, Thomas Dr. (4) Kieback, Elisa Dr. (1) Kopp, Joachim Dr. (1) Landthaler, Markus Prof. Dr. (7) Lee, Young-Ae Prof. Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (1) Lupianez Garcia, Dario Jesus Dr. (1) Obermayer-Wasserscheid, Benedikt Dr. (1) Ohler, Uwe Prof. Dr. (2) Pezzutto, Antonio Prof. Dr. (2) Rajewsky, Nikolaus Prof. Dr. (1) Selbach, Matthias Prof. Dr. (2) Uckert, Wolfgang Prof. Dr. (5) Willimsky, Gerald Dr. (4) Zauber, Henrik Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (14) (-) Bunse, Mario Dr. (1) (-) Wyler, Emanuel Dr. (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) (-) 2005 (10) 2006 (1) 2007 (5) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (8) 2013 (11) 2014 (3) 2015 (7) (-) 2016 (6) 2017 (11) 2018 (5) 2019 (9) 2020 (3) 2021 (15) 2022 (19) 2023 (14) 2024 (4) Cellular Neurosciences (2) Computational Regulatory Genomics (1) Developmental Biology / Signal Transduction (1) Experimental Ultrahigh-Field MR (4) Genetics of Metabolic and Reproductive Disorders (1) Genome Engineering & Disease Models (2) Immune Regulation and Cancer (3) Magnetic Resonance (4) Mobile DNA (1) (-) Molecular Immunology and Gene Therapy (15) Proteome Dynamics (1) (-) RNA Biology and Posttranscriptional Regulation (1) Transgenics (2) 16 Results: Active Filter: Blankenstein, Thomas Prof. Dr.Bunse, Mario Dr.Wyler, Emanuel Dr.Molecular Immunology and Gene TherapyRNA Biology and Posttranscriptional Regulation20052016 Sort: Result score Newest to oldest Oldest to newest January 01, 2005 / Trends Mol Med Immunotherapy: target the stroma to hit the tumor T. Kammertoens T. Schueler T. Blankenstein July 01, 2005 / Hum Gene Ther Redirecting human T lymphocytes toward renal cell carcinoma specificity by retroviral transfer of T cell receptor genes B. Engels E. Noessner B. Frankenberger T. Blankenstein D.J. Schendel W. Uckert July 05, 2005 / World J Urol Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells B. Frankenberger S. Regn C. Geiger E. Noessner C.S. Falk H. Pohla M. Javorovic T. Silberzahn S. Wilde A. Buchner M. Siebels R. Oberneder G. Willimsky A. Pezzutto T. Blankenstein D.J. Schendel September 01, 2005 / Nature Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance G. Willimsky T. Blankenstein May 20, 2005 / Bioforum Gentherapie mit T-Zellrezeptor modifizierten Zellen W. Uckert T. Blankenstein January 01, 2005 / Canc Res CY15, a malignant histiocytic tumor that is phenotypically similar to immature dendritic cells T. Kammertoens R. Willebrand B. Erdmann L. Li Y. Li B. Engels W. Uckert T. Blankenstein January 01, 2005 / Int J Cancer Tumor-induced antibodies resemble the response to tissue damage S. Preiss T. Kammertoens C. Lampert G. Willimsky T. Blankenstein January 01, 2005 / Curr Opin Immunol The role of tumor stroma in the interaction between tumor and immune system T. Blankenstein January 01, 2005 / Clin Cancer Res Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLs B. Frankenberger H. Pohla E. Noessner G. Willimsky B. Papier A. Pezzutto J. Kopp R. Oberneder T. Blankenstein D.J. Schendel January 01, 2005 / Int J Cancer Necrotic death but not irradiation abolishes costimulation of T-cell effector functions and survival by CD80-expressing tumor cells L. Staerck C. Scholz T. Blankenstein B. Doerken P.T. Daniel Pagination Current page 1 Page 2 Next page Next › Last page Last »
January 01, 2005 / Trends Mol Med Immunotherapy: target the stroma to hit the tumor T. Kammertoens T. Schueler T. Blankenstein
July 01, 2005 / Hum Gene Ther Redirecting human T lymphocytes toward renal cell carcinoma specificity by retroviral transfer of T cell receptor genes B. Engels E. Noessner B. Frankenberger T. Blankenstein D.J. Schendel W. Uckert
July 05, 2005 / World J Urol Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells B. Frankenberger S. Regn C. Geiger E. Noessner C.S. Falk H. Pohla M. Javorovic T. Silberzahn S. Wilde A. Buchner M. Siebels R. Oberneder G. Willimsky A. Pezzutto T. Blankenstein D.J. Schendel
September 01, 2005 / Nature Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance G. Willimsky T. Blankenstein
May 20, 2005 / Bioforum Gentherapie mit T-Zellrezeptor modifizierten Zellen W. Uckert T. Blankenstein
January 01, 2005 / Canc Res CY15, a malignant histiocytic tumor that is phenotypically similar to immature dendritic cells T. Kammertoens R. Willebrand B. Erdmann L. Li Y. Li B. Engels W. Uckert T. Blankenstein
January 01, 2005 / Int J Cancer Tumor-induced antibodies resemble the response to tissue damage S. Preiss T. Kammertoens C. Lampert G. Willimsky T. Blankenstein
January 01, 2005 / Curr Opin Immunol The role of tumor stroma in the interaction between tumor and immune system T. Blankenstein
January 01, 2005 / Clin Cancer Res Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLs B. Frankenberger H. Pohla E. Noessner G. Willimsky B. Papier A. Pezzutto J. Kopp R. Oberneder T. Blankenstein D.J. Schendel
January 01, 2005 / Int J Cancer Necrotic death but not irradiation abolishes costimulation of T-cell effector functions and survival by CD80-expressing tumor cells L. Staerck C. Scholz T. Blankenstein B. Doerken P.T. Daniel